CooperCompanies Q1 revenue $1.024B, non-GAAP EPS $1.10; raises FY2026 guidance

COOPER COMPANIES, INC.

2026-Q1 EPS reported $0.66 revenue$1,024,100,000

Q1 revenue $1.024B (+6% reported, +3% organic); GAAP EPS $0.66 (+27%), non-GAAP EPS $1.10 (+20%).
CVI revenue $695.1M (+8% reported, +3% organic); Toric/multifocal +10% reported, sphere +5%.
CSI revenue $329.0M (+3% reported, +2% organic); Fertility +6% reported, Office/surgical +2%.
FY2026 guidance raised: revenue $4.306-$4.346B, non-GAAP EPS $4.58-$4.66, free cash flow $600-$625M.
Repurchased $92.5M in stock (~1.1M shares at avg $82.04); $873.9M remaining authorization.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

COOPER COMPANIES, INC. reported fiscal first quarter ended January 31, 2026 results: revenue $1.024 billion, EPS $0.66. Guidance raised.

Period: fiscal first quarter ended January 31, 2026
Revenue: $1.024 billion
EPS: $0.66
Guidance: raised
Result: reported results

Exact text from the filing

(Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2026. • First quarter 2026 revenue of $1.024 billion, up 6%, or up 3% organically, from last year's first quarter. • First quarter 2026 GAAP diluted earnings per share (EPS) of $0.66, up $0.14 or 27% from last year's first quarter.

View on SEC.gov

Browse all earnings releases →

COOPER COMPANIES, INC. filing history →

Source: SEC EDGAR

accession 0001628280-26-015231

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.